Skip to main content

TG THERAPEUTICS, INC.

For the period ended Mar 31, 2026. Filed May 6, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 6, 2026

TGTX$59.83+3.2%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

Table of Contents

SPECIAL CAUTIONARY NOTICE REGARDING FORWARD-LOOKING STATEMENTS3
​​
SUMMARY RISK FACTORS4
PART IFINANCIAL INFORMATION6
Item 1Financial Statements:6
Condensed Consolidated Balance Sheets6
Condensed Consolidated Statements of Operations (unaudited)7
Condensed Consolidated Statements of Changes in Stockholders’ Equity (unaudited)8
Condensed Consolidated Statements of Cash Flows (unaudited)9
Notes to Condensed Consolidated Financial Statements (unaudited)10
Item 2Management’s Discussion and Analysis of Financial Condition and Results of Operations29
Item 3Quantitative and Qualitative Disclosures About Market Risk37
​
Item 4Controls and Procedures37
PART IIOTHER INFORMATION38
Item 1Legal Proceedings38
​
Item 1ARisk Factors38
​​​
Item 2Unregistered Sales of Equity Securities and Use of Proceeds89
​​​
Item 3Defaults of Senior Securities89
Item 4Mine Safety Disclosures89
​​​
Item 5Other Information89
​​​
Item 6Exhibits90

​

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.